Cold is an infectious disease that affects the respiratory system. The common symptoms for cold include sneezing, sore throat, a stuffy nose, and coughing. Cold remedies are used to treat cold in immunosuppressed individuals.
The global Cough and Cold Remedie market was valued at US$ 40130 million in 2023 and is anticipated to reach US$ 58780 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
The Cough and Cold Remedies 麻豆原创 is driven by the recurring nature of respiratory ailments and seasonal illnesses, such as coughs and colds, which create a consistent demand for over-the-counter remedies. Cough and cold remedies, including cough syrups, decongestants, and throat lozenges, provide individuals with relief from common symptoms and discomfort associated with these ailments. As consumers prioritize self-care and symptom management, the market for these remedies continues to expand. The advent of innovative formulations and delivery methods further fuels market growth. However, a significant challenge for this market is the need to address regulatory and safety concerns surrounding certain ingredients, ensuring that remedies are effective and safe for users. Overcoming the evolving landscape of cold and flu viruses and the need to tailor products to address specific symptoms pose ongoing challenges. Additionally, the market faces competition from alternative therapies, natural remedies, and preventive measures. Striking a balance between providing accessible and reliable remedies for symptom relief while navigating evolving consumer preferences and safety considerations is crucial for the continued growth of the Cough and Cold Remedies 麻豆原创.
This report aims to provide a comprehensive presentation of the global market for Cough and Cold Remedie, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cough and Cold Remedie.
Report Scope
The Cough and Cold Remedie market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cough and Cold Remedie market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cough and Cold Remedie companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Reckitt Benckiser Group
Johnson & Johnson
GlaxoSmithKline
Novartis
Bayer
AstraZeneca
Sun Pharmaceutical Industries
Pfizer
Prestige Brands Holdings
Procter & Gamble
Segment by Type
Antihistamines
Expectorants
Bronchodilators
Decongestants
Antibiotics
Others
Segment by Application
OTC
Rx
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cough and Cold Remedie companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Cough and Cold Remedie 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antihistamines
1.2.3 Expectorants
1.2.4 Bronchodilators
1.2.5 Decongestants
1.2.6 Antibiotics
1.2.7 Others
1.3 麻豆原创 by Application
1.3.1 Global Cough and Cold Remedie 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 OTC
1.3.3 Rx
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cough and Cold Remedie 麻豆原创 Perspective (2019-2030)
2.2 Cough and Cold Remedie Growth Trends by Region
2.2.1 Global Cough and Cold Remedie 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cough and Cold Remedie Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Cough and Cold Remedie Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Cough and Cold Remedie 麻豆原创 Dynamics
2.3.1 Cough and Cold Remedie Industry Trends
2.3.2 Cough and Cold Remedie 麻豆原创 Drivers
2.3.3 Cough and Cold Remedie 麻豆原创 Challenges
2.3.4 Cough and Cold Remedie 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cough and Cold Remedie Players by Revenue
3.1.1 Global Top Cough and Cold Remedie Players by Revenue (2019-2024)
3.1.2 Global Cough and Cold Remedie Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Cough and Cold Remedie 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cough and Cold Remedie Revenue
3.4 Global Cough and Cold Remedie 麻豆原创 Concentration Ratio
3.4.1 Global Cough and Cold Remedie 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cough and Cold Remedie Revenue in 2023
3.5 Cough and Cold Remedie Key Players Head office and Area Served
3.6 Key Players Cough and Cold Remedie Product Solution and Service
3.7 Date of Enter into Cough and Cold Remedie 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Cough and Cold Remedie Breakdown Data by Type
4.1 Global Cough and Cold Remedie Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Cough and Cold Remedie Forecasted 麻豆原创 Size by Type (2025-2030)
5 Cough and Cold Remedie Breakdown Data by Application
5.1 Global Cough and Cold Remedie Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Cough and Cold Remedie Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Cough and Cold Remedie 麻豆原创 Size (2019-2030)
6.2 North America Cough and Cold Remedie 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cough and Cold Remedie 麻豆原创 Size by Country (2019-2024)
6.4 North America Cough and Cold Remedie 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cough and Cold Remedie 麻豆原创 Size (2019-2030)
7.2 Europe Cough and Cold Remedie 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cough and Cold Remedie 麻豆原创 Size by Country (2019-2024)
7.4 Europe Cough and Cold Remedie 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cough and Cold Remedie 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Cough and Cold Remedie 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cough and Cold Remedie 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Cough and Cold Remedie 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cough and Cold Remedie 麻豆原创 Size (2019-2030)
9.2 Latin America Cough and Cold Remedie 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cough and Cold Remedie 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Cough and Cold Remedie 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cough and Cold Remedie 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Cough and Cold Remedie 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cough and Cold Remedie 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Cough and Cold Remedie 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Reckitt Benckiser Group
11.1.1 Reckitt Benckiser Group Company Detail
11.1.2 Reckitt Benckiser Group Business Overview
11.1.3 Reckitt Benckiser Group Cough and Cold Remedie Introduction
11.1.4 Reckitt Benckiser Group Revenue in Cough and Cold Remedie Business (2019-2024)
11.1.5 Reckitt Benckiser Group Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Cough and Cold Remedie Introduction
11.2.4 Johnson & Johnson Revenue in Cough and Cold Remedie Business (2019-2024)
11.2.5 Johnson & Johnson Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Detail
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Cough and Cold Remedie Introduction
11.3.4 GlaxoSmithKline Revenue in Cough and Cold Remedie Business (2019-2024)
11.3.5 GlaxoSmithKline Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Cough and Cold Remedie Introduction
11.4.4 Novartis Revenue in Cough and Cold Remedie Business (2019-2024)
11.4.5 Novartis Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Cough and Cold Remedie Introduction
11.5.4 Bayer Revenue in Cough and Cold Remedie Business (2019-2024)
11.5.5 Bayer Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Cough and Cold Remedie Introduction
11.6.4 AstraZeneca Revenue in Cough and Cold Remedie Business (2019-2024)
11.6.5 AstraZeneca Recent Development
11.7 Sun Pharmaceutical Industries
11.7.1 Sun Pharmaceutical Industries Company Detail
11.7.2 Sun Pharmaceutical Industries Business Overview
11.7.3 Sun Pharmaceutical Industries Cough and Cold Remedie Introduction
11.7.4 Sun Pharmaceutical Industries Revenue in Cough and Cold Remedie Business (2019-2024)
11.7.5 Sun Pharmaceutical Industries Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Cough and Cold Remedie Introduction
11.8.4 Pfizer Revenue in Cough and Cold Remedie Business (2019-2024)
11.8.5 Pfizer Recent Development
11.9 Prestige Brands Holdings
11.9.1 Prestige Brands Holdings Company Detail
11.9.2 Prestige Brands Holdings Business Overview
11.9.3 Prestige Brands Holdings Cough and Cold Remedie Introduction
11.9.4 Prestige Brands Holdings Revenue in Cough and Cold Remedie Business (2019-2024)
11.9.5 Prestige Brands Holdings Recent Development
11.10 Procter & Gamble
11.10.1 Procter & Gamble Company Detail
11.10.2 Procter & Gamble Business Overview
11.10.3 Procter & Gamble Cough and Cold Remedie Introduction
11.10.4 Procter & Gamble Revenue in Cough and Cold Remedie Business (2019-2024)
11.10.5 Procter & Gamble Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Reckitt Benckiser Group
Johnson & Johnson
GlaxoSmithKline
Novartis
Bayer
AstraZeneca
Sun Pharmaceutical Industries
Pfizer
Prestige Brands Holdings
Procter & Gamble
听
听
*If Applicable.